Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Selenium in the Treatment of Arsenic Toxicity and Cancers (SETAC)

This study has been completed.
Sponsor:
Collaborators:
American Cancer Society, Inc.
Information provided by (Responsible Party):
Julian Spallholz, Texas Tech University
ClinicalTrials.gov Identifier:
NCT01442727
First received: September 22, 2011
Last updated: October 6, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)